Hummingbird ICE Study - Observational Study Using Philips VeriSight Pro ICE Catheter
Summary
NIH registered an observational study (NCT07552272) titled 'Hummingbird ICE Study' on ClinicalTrials.gov, posted April 27, 2026. The study will collect data and ultrasound images using the Philips VeriSight Pro intracardiac echocardiography (ICE) catheter to assess safety and effectiveness and to support development of the VeriSight Pro imaging platform. Conditions studied include atrial fibrillation, valve disease, atrial septal defect, patent foramen ovale, and tricuspid valve disease.
“The goals of this observational study are to collect data and ultrasound images using the Philips VeriSight Pro intracardiac echocardiography (ICE) catheter to assess safety and effectiveness and to support development efforts of the VeriSight Pro imaging platform.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
The Hummingbird ICE Study is a newly registered observational study on ClinicalTrials.gov (NCT07552272) posted April 27, 2026. The study will use the Philips VeriSight Pro ICE catheter to collect ultrasound imaging data across multiple cardiac conditions including atrial fibrillation, valve disease, atrial septal defect, patent foramen ovale, and tricuspid valve disease. No regulatory obligations are created by this registration.
Medical device manufacturers and healthcare institutions involved in ICE catheter research or development should be aware of this study as it may inform competitive intelligence on the VeriSight Pro imaging platform. Clinical investigators considering similar intracardiac echocardiography studies may reference this registry for protocol design and outcome measures.
Archived snapshot
Apr 27, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Hummingbird ICE Study
Observational NCT07552272 Kind: OBSERVATIONAL Apr 27, 2026
Abstract
The goals of this observational study are to collect data and ultrasound images using the Philips VeriSight Pro intracardiac echocardiography (ICE) catheter to assess safety and effectiveness and to support development efforts of the VeriSight Pro imaging platform.
Conditions: ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, Atrial Fibrillation (AF), Valve Disease, Heart, Atrial Septal Defect, Patent Foramen Ovale, Tricuspid Valve Disease
Interventions: ICE Image Guidance
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.